Alvotech, the Iceland-based biosimilar company, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT04, Alvotech’s proposed biosimilar to the reference product Stelara®. The objective of the study is to…
Verily to boost clinical research expertise with SignalPath acquisition
Alphabet subsidiary Verily has signed an agreement to acquire a clinical trial management system (CTMS) developer SignalPath to strengthen its clinical research capabilities. Established in 2014, SignalPath designed its CTMS platform to enhance the ease, quality and efficacy with which…
Labcorp and CCORN partner to enable trials in diverse cancer patients
Labcorp and Community Clinical Oncology Research Network (CCORN) have partnered to gain improved insights into the effect of disparities in precision medicine for cancer. The companies expect that data from a patient registry and biobank can aid in designing oncology…
Hoping to Change the Game, Bharat’s Intranasal Vaccine Moves Forward
When the first vaccine was authorized in December, it felt like a light at the end of a long, dark, pandemic tunnel. The mRNA vaccines, in particular, showed high efficacy rates at preventing severe illness from SARS-CoV-2. Yet scientists issued…
WHO launches Solidarity PLUS to assess three new drugs for Covid-19
The World Health Organization (WHO) has launched the new phase of its Solidarity clinical trial to assess three new drugs to treat patients hospitalised with Covid-19. Named Solidarity PLUS, the new trial will investigate artesunate, imatinib and infliximab, which are…
Five times more virtual trial job postings from pharma and CROs in 18 months
Covid-19 lockdowns and social distancing measures have caused significant disruptions to clinical trials and accelerated the use of virtual trials. Companies that had not considered this model before have had no option but to rapidly implement new technologies and procedures…
